Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
about
Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysisRecent Advances in Chemotherapy and Surgery for Colorectal Liver MetastasesIdentification of liver metastases with probe-based confocal laser endomicroscopy at two excitation wavelengths.Reresection of Colorectal Liver Metastasis with Vena Cava Resection.Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastasesTwo-dimensional assessment of submillimeter cancer-free margin area in colorectal liver metastasesALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases.Impact of surgical margin clearance for resection of secondary hepatic malignancies.The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion.Potential benefit of rotational radiation therapy.Management of patients with colorectal liver metastasis in eleven questions and answers.Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.Precoagulation-assisted parenchyma-sparing laparoscopic liver surgery: rationale and surgical technique.Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver MetastasesExtending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases.Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases.Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases: A Propensity Score Matching Analysis.Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer.Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases.Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases
P2860
Q26774704-AF176D02-D859-4817-8B9F-891E0822EFB6Q28067408-AAF38C02-2A6C-4216-8C1F-442C4AB077F8Q33578266-FAD32E25-2FD7-4E5F-AF45-20D6F9F92080Q36759594-B4A230EB-C866-466B-93C1-FDA35D9B0D0CQ36945965-9B544460-656A-41EF-8374-79C3B05DEACDQ37328011-24B6DF27-1E3A-4A14-AA30-9E4DCD744C87Q37686394-11DD4E22-AA4B-49D2-AB04-05AC8D4E1B1FQ38667823-178EA993-EC62-4ADC-8105-DD6023DA863AQ38684846-C6FB98B1-B852-48B6-B8EB-3F1A472F258EQ38773082-5B40D9AE-FE16-4040-8001-C7704226407EQ38811107-65991090-648E-4823-BA59-E4ABF8BF3B45Q38925427-AC154ACC-C79C-4217-8E1A-91E1B12DCF8EQ39573768-9B350ABD-D2A7-4BD7-845F-53EFF2C0F89DQ39626850-B94F9081-BA81-4854-8B4F-77DC7ED1901DQ40317208-BCEE52BD-0E5E-4E7A-AA93-62CE36465DC1Q40439753-3FE33607-D61C-4C12-AA5D-BCCDBF2B2AECQ41129943-A58B6B99-D8C1-4895-8E2A-EF48D400FE60Q47096503-BA2F863A-AA0E-4954-BA15-0AA8DDE09413Q47189523-DE84A65E-0F18-4923-A86E-E168BDCBBD5BQ48146966-ECACCF59-38F2-4291-8EF9-B8F2433CEA6EQ48371323-8A245768-D30C-4D5A-84C2-6836FEB9BD57Q49580510-E3B09710-96E9-4A4A-B316-638394C33B43Q50001900-005C9DEF-8DBD-4E2A-AB7D-621FB971D3CCQ50017224-31AD6ED9-A12E-4478-BD43-4E2E7C7069E6Q50060279-ECFBAFD7-5DC0-4464-BD85-00F44AF24326Q53017398-084824B4-7D7D-42CC-A9D3-0022FE3960A7Q53194818-20207FA1-E275-429B-B019-94873E063F5EQ58566721-EFAFE6A7-897C-40A9-8F7E-8DAA3B671D97
P2860
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Resection margin and survival ...... chnique or biologic surrogate?
@ast
Resection margin and survival ...... chnique or biologic surrogate?
@en
type
label
Resection margin and survival ...... chnique or biologic surrogate?
@ast
Resection margin and survival ...... chnique or biologic surrogate?
@en
prefLabel
Resection margin and survival ...... chnique or biologic surrogate?
@ast
Resection margin and survival ...... chnique or biologic surrogate?
@en
P2093
P2860
P1433
P1476
Resection margin and survival ...... chnique or biologic surrogate?
@en
P2093
Bas Groot Koerkamp
Eran Sadot
Julie N Leal
Leslie H Blumgart
Michael I DʼAngelica
Mithat Gonen
Nancy Kemeny
Peter J Allen
Ronald P DeMatteo
William R Jarnagin
P2860
P304
476-85; discussion 483-5
P356
10.1097/SLA.0000000000001427
P407
P577
2015-09-01T00:00:00Z